Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01984645 · ClinicalTrials.gov registry record · NA

Primary-care-provider Identification And Notification

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
7,023
Enrollment target

NCT01984645: Completed NA study, sponsored by Columbia University.

NCT01984645 is a NA study that has completed, run by Columbia University. The registered enrollment target is 7,023 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (401% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01984645, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
7,023 participants
Enrollment target

Study Summary

New York-Presbyterian Hospital has created a system that notifies its primary care providers whenever their patients are admitted to the hospital. In this study, the investigators want to evaluate how accurate this system is and how it is affecting the primary providers and their health care delivery.

Primary Outcome

The investigators will measure the time from each patient's discharge until their first follow-up visit in the outpatient setting. The investigators hypothesize that the automated notification will result is earlier post-discharge followups.

Interventions

  • OTHER Notification

Trial Details

FieldValue
Enrollment Target 7,023 participants
Start Date 2012-09
Est. Completion 2015-07
Phase NA
Columbia University

958 total trials

What the finished NCT01984645 record still lists

NCT01984645 is an interventional study that assigns participants to a tested intervention. Its 7,023 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (401% higher).

The record links to 0 conditions, and to 1 intervention - of which Notification is the first listed.

NCT01984645 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01984645 about?

NCT01984645 is a clinical study titled "Primary-care-provider Identification And Notification". New York-Presbyterian Hospital has created a system that notifies its primary care providers whenever their patients are admitted to the hospital. In this study, the investigators want to evaluate how accurate this system is and how it is affecting the primary providers and their health care deliver...

What is the current status of trial NCT01984645?

This trial is currently completed. It is a NA study. The enrollment target is 7,023 participants. The study started on 2012-09. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01984645?

The interventions under investigation include: Notification (OTHER).

Who is sponsoring clinical trial NCT01984645?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01984645's enrollment target sits among peer trials

7,023 21st of 2000 higher than 1,980 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00260585 · 7,000 participants

    Esophageal Cancer Risk Registry

  • NCT04118660 · 7,000 participants

    Thoracic Specimen Registry

  • NCT07106879 · 7,000 participants

    Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

  • NCT07140744 · 7,000 participants · NA

    A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01984645, the US trial registry maintained by the National Library of Medicine. NCT01984645 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.